Günter Müller
Institute for Diabetes and Obesity, Germany
Biography
Günter Müller has completed his PhD in Genetics at the Ludwig-Maximilians-University (LMU) Munich. After postdoctoral studies at the Universities of Ulm and Heidelberg and habilitation at the LMU he was engaged in drug discovery for type II diabetes at pharmaceutical companies Hoechst AG, Aventis and Sanofi at Frankfurt/Germany for more than 20 years. Currently, he is group leader for biomarker research at the Helmholtz Center Munich. He has published more than 150 original papers, reviews, book chapters and patents.
Abstract
Abstract : Serum Signatures of Low Bias Are Correlated with (Pre-)Diabetic States in Rats